Supplies water treatment systems and related solutions. Distributes laboratory instrumentation and analytical devices, including spectrophotometers and chromatographs. Now — the numbers.
This is an established company with proven profits.
An average decline of 11% a year over the last 4 years — the most striking risk in this picture.
If every debt were paid off today, $4.9M would still be left in the vault — a solid cushion for hard times.
The market pays 74.6× for every dollar this company earns in a year — a price that already assumes things go well.
Against companies in its own sector, it looks cheaper than 80% of them.
No analyst target is on record for this company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
Clearly below the class average.
The price looks reasonable next to what the company earns.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Growth: Sales growth trails the sector average.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
The stock trades 39% below its peak. The market has trimmed its expectations for the company.
There is $5.2M in the vault; even if every debt were paid off, $4.9M would remain.
Over the last 4 years, sales fell about 11% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.
The company’s market value is 75 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, CLWT sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: CLWT does earn real profits — but on our report card it still sits behind its class. The real debate isn’t the quality of the business — it’s what that quality should cost.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.